HotSpot Therapeutics, Inc. v. Nurix Therapeutics, Inc.

1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 7 HOTSPOT THERAPEUTICS, INC., Case No. 22-cv-04109-TSH

8 Plaintiff,

PUBLIC VERSION OF DISCOVERY

9 v. ORDER AT ECF NO. 173

10 NURIX THERAPEUTICS, INC., Re: Dkt. No. 157 11 Defendant.

12 13 Nurix moves to compel concerning certain requests for production (“RFPs”) and Rule 14 30(b)(6) deposition topics. ECF No. 157. The Court held a hearing on January 8, 2024, and now 15 issues this order. 16 A. Which RFPs Did Nurix Properly Move On? 17 For the RFPs, Nurix has a chart that lists a number of RFPs and then a column entitled 18 “status of HotSpot Production.” This chart does not contain any arguments concerning the 19 relevance of the requested materials, and the Court is of the view that a moving party should 20 explain why the relief it is seeking ought to be granted. Merely gesturing at a long list of RFPs is 21 unfair to the opposing party, which has no specific argument to respond to. Accordingly, the 22 Court does not consider the mere listing of an…